Abstract
AbstractMotivationOne of the main goals of precision oncology is to predict the response of a patient to a given cancer treatment based on their genomic profile. Although current models for drug response prediction are becoming more accurate, they are also ‘black boxes’ and cannot explain their predictions, which is of particular importance in cancer treatment. Many models also do not leverage prior biological knowledge, such as the hierarchical information on how proteins form complexes and act together in pathways.ResultsIn this work, we use this prior biological knowledge to form the architecture of a deep neural network to predict cancer drug response from cell line gene expression data. We find that our approach not only has a low prediction error compared to baseline models but also allows meaningful interpretation of the network. These interpretations can both explain predictions made and discover novel connections in the biological knowledge that may lead to new hypotheses about mechanisms of drug action.AvailabilityCode at https://github.com/osnow/BDKANNSupplementary informationIncluded with submission
Publisher
Cold Spring Harbor Laboratory
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献